Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies
The University of Texas Health Science Center, Houston
The University of Texas Health Science Center, Houston
National Cancer Institute (NCI)
University of Michigan Rogel Cancer Center
Children's Oncology Group
Loyola University
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Brown University
Masonic Cancer Center, University of Minnesota
University of Texas Southwestern Medical Center
University of Southern California
OHSU Knight Cancer Institute
University of Miami
NYU Langone Health
Fred Hutchinson Cancer Center
Mesoblast, Ltd.
City of Hope Medical Center
University of California, San Francisco
Northwestern University